Bacteroides fragilis (Veillon and Zuber) Castellani and Chalmers (ATCC® 25285D-5)

Strain Designations: Genomic DNA from Bacteroides fragilis Strain VPI 2553 [ATCC® 25285™]  /  Type Strain: yes  /  Biosafety Level: 1

Strain Designations Genomic DNA from Bacteroides fragilis Strain VPI 2553 [ATCC® 25285™]
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format dried
At least 5 µg in 1X TE buffer
OD260/OD280: 1.6 to 2.1
Preceptrol® no
Genome Sequenced Strain

Bacteroides fragilis NCTC 9343, complete genome

Type Strain yes
Comments
Genomic DNA from genome sequenced strain
This preparation of high molecular weight DNA is appropriate for use in the polymerase chain reaction (PCR)* process and other molecular biology applications.
*the PCR process is covered by patents owned by Hoffmann-La Roche Inc. Use of the PCR process requires a license.
Name of Depositor ATCC
Cross References

Nucleotide (GenBank) : X83935 B.fragilis 16S rRNA (ATCC 25285T).

Nucleotide (GenBank) : AX110196 Sequence 929 from Patent WO0123604.

Nucleotide (GenBank) : AF280705 Bacteroides fragilis isolate ATCC 25285 RecA (recA) gene, partial cds.

Nucleotide (GenBank) : U05887 Bacteroides fragilis ATCC 25285 beta-lactamase (cepA-85) gene, complete cds.

Nucleotide (GenBank) : AF280642 Bacteroides fragilis isolate ATCC 25285 glutamine synthetase (glnA) gene, partial cds.

Nucleotide (GenBank) : CR626927 Bacteroides fragilis NCTC 9343, complete genome